Description:
CALGB: 10603 Registration Worksheet For Non-North American Sites Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7456F79A-F2F6-BFB6-E040-BB89AD436544
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7456F79A-F2F6-BFB6-E040-BB89AD436544Keywords:
Versions (4)
- 9/19/12 9/19/12 -
- 1/9/15 1/9/15 - Martin Dugas
- 1/9/15 1/9/15 - Martin Dugas
- 9/20/21 9/20/21 -
Uploaded on:
September 20, 2021
DOI:
To request one please log in.License :
Creative Commons BY-NC 3.0 LegacyModel comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Leukemia DRKS00003845 NCT00651261 Registration - CALGB: 10603 Registration Worksheet For Non-North American Sites - 2945236v1.0
A Randomized Phase III Trial to Evaluate the Potential Utility of a Genomic Prognostic Model to Identify Stage I Non-Small Cell Lung Cancer NSCLC) Patients as Candidates for Adjuvant Chemotherapy
- StudyEvent: CALGB: 10603 Registration Worksheet For Non-North American Sites